Based on SEC filing data. A pharmaceutical corporation based in Boston, MA raised $55.0M in Series B equity funding. The company is in the growth stage of development within the pharmaceutical sector.
Get notified the moment Afferent Pharmaceuticals, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.